Last Update 30 07 2017
NEWS
  • 21/10/2016
    FDA Approves Merck’s Zinplava (bezlotoxumab) to Reduce Recurrence of Clostridium difficile Infection

  • 20/10/2016
    FDA Grants Accelerated Approval to Lartruvo (olaratumab) for Advanced Soft Tissue Sarcoma -

  • 19/01/2017
    FDA Approves Trulance (plecanatide) for Chronic Idiopathic Constipation

  • 31/01/2017
    Teva Announces FDA Approval of ArmonAir RespiClick (fluticasone propionate) for Maintenance Treatment of Asthma

  • 30/01/2017
    Teva Announces FDA Approval of AirDuo RespiClick (fluticasone propionate and salmeterol) for Maintenance Treatment of Asthma

  • 08/02/2017
    FDA Approves Amgen's Parsabiv (etelcalcetide) for Secondary Hyperparathyroidism in Adult Patients on Hemodialysis

  • 09/02/2017
    FDA Approves Emflaza (deflazacort) to treat Duchenne Muscular Dystrophy


  • Equivamed provides immediate online access to up-to-date drugs name information sourced from an extensive range of the world's most trusted resources.
  • How do I Register and Activate an Online Subscription?
  • Click 'Subscription ' on the Journal homepage. Go to the next page Choose one month or one year subscription . fill out the form for a new account Choose a payment method and sends
  • Create a username & password along with inputting a valid email address. Click 'Continue' when complete
  • NEW PRODUCTS
    • new product 香砂养胃丸
    • new product 十全大补丸
    • new product 杞菊地黄丸
    • new product エイムゲン
    • new product アブラキサン点滴静注用100mg
    • new product インデラル錠10mg、インデラル錠20mg
    • new product YERVOY (ipilimumab)
    • new product וימפט 50 מ"ג
    • new product פרג'טה
    • new product סיברי בריזהלר 50 מק"ג
    • new product אריוודג'
    • new product בייאטה 10 מק"ג
    • new product בייאטה 5 מק"ג
    • new product קפרלסה 100 מ"ג
    • new product Hetlioz (tasimelteon)
    • new product Vimizim (elosufase alfa)
    • new product Myalept (metreleptin)
    • new product Tivorbex (indomethacin)
    • new product Northera (droxidopa)
    • new product Otezla (apremilast)
    • new product Alprolix (coagulation factor IX (recombinant))
    • new product Evzio (naloxone hydrochloride)
    • new product Cyramza (ramucirumab)
    • new product Sylvant (siltuximab)
    • new product Zykadia (ceritinib)
    • new product Zontivity (vorapaxar)
    • new product Entyvio (vedolizumab)
    • new product Dalvance (dalbavancin)
    • new product Omidria (ketorolac and phenylephrine)
    • new product Jublia (efinaconazole)
    • new product Sivextro (tedizolid)
    • new product Beleodaq (belinostat)
    • new product Kerydin (tavaborole)
    • new product Zydelig (idelalisib)
    • new product Striverdi Respimat (olodaterol)
    • new product Belsomra (suvorexant)
    • new product Triumeq (abacavir, dolutegravir and lamivudine)
    • new product Keytruda (pembrolizumab)
    • new product Trulicity (dulaglutide)
    • new product Iluvien (fluocinolone acetonide)
    • new product Vitekta (elvitegravir)
    • new product Tybost (cobicistat)
    • new product Harvoni (ledipasvir and sofosbuvir)
    • new product Akynzeo (netupitant and palonosetron)
    • new product Lumason (sulfur hexafluoride lipid microsphere)
    • new product Blincyto (blinatumomab)
    • new product Xtoro (finafloxacin)
    • new product Zerbaxa (ceftolozane and tazobactam)
    • new product Viekira Pak (ombitasvir/paritaprevir/ritonavir with dasabuvir)
    • new product Lynparza (olaparib)
    • new product Natpara (recombinant human parathyroid hormone)
    • new product Evotaz (atazanavir and cobicistat)
    • new product Prezcobix (cobicistat and darunavir)
    • new product Glyxambi (empagliflozin and linagliptin)
    • new product Pazeo (olopatadine hydrochloride)
    • new product Ibrance (palbociclib)
    • new product Farydak (panobinostat)
    • new product Avycaz (avibactam and ceftazidime)
    • new product Cresemba (isavuconazonium)
    • new product Unituxin (dinutuximab)
    • new product Orkambi (ivacaftor and lumacaftor)
    • new product Entresto (sacubitril and valsartan)
    • new product Rexulti (brexpiprazole)
    • new product Technivie (ombitasvir, paritaprevir and ritonavir)
    • new product Odomzo (sonidegib)
    • new product Daklinza (daclatasvir)
    • new product Praluent (alirocumab)
    • new product Repatha (evolocumab)
    • new product Varubi (rolapitant)
    • new product Xuriden (uridine triacetate)
    • new product Vraylar (cariprazine)
    • new product Imlygic (talimogene laherparepvec)
    • new product Nuplazid (pimavanserin)
    • new product Tecentriq (atezolizumab)
    • new product Axumin (fluciclovine F 18)